Pharmaceuticals

Trump Announces 100% Tariffs on Pharma Imports

Published SEP 26 2025

Story

Above: Tablets of medicines kept in Kolkata, India on Aug. 27, 2025. Image credit: Dibyangshu Sarkar/AFP/Getty

The Facts

President Donald Trump announced Thursday that brand-name or patented pharmaceutical products will face a 100% tariff starting Oct. 1, with exemptions for companies building manufacturing plants in the U.S., while Asian pharmaceutical stocks declined Friday.
The Wall Street Journal
CBC
The pharmaceutical tariffs will not apply to companies that have broken ground or are under construction on U.S. manufacturing facilities, though it remains unclear how existing U.S. operations will be affected by the new levies.
CNBC
9News Australia
Financial Times
The Trump administration had earlier threatened pharma tariffs of up to 250%. However, Trump had also told CNBC in August he would raise the rate over a year or more.
News.com.au
Guardian
Pharmaceutical companies including Eli Lilly, Johnson & Johnson and AstraZeneca have announced hundreds of billions in U.S. manufacturing investments, with Eli Lilly unveiling plans for facilities worth $11.5 billion in Houston and Virginia.
The Telegraph
CNN
The U.S. imported nearly $233 billion in pharmaceutical and medicinal products in 2024, with industry experts warning that tariffs could lead to immediate price increases and potential medication shortages for American consumers.
CBC
The Telegraph
This comes as Trump also announced additional tariffs of 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture, and 25% on heavy trucks — citing national security concerns and protection of domestic manufacturers from foreign competition.
CNN
9News Australia
The Hill

Sources Split

LEFT

CENTER

RIGHT

ESTAB
CRIT

CENTER

PRO
ESTAB

The Spin

Pro-Trump narrative

America's dangerous dependence on foreign drug suppliers threatens national security and patient safety. China controls 90% of active pharmaceutical ingredients, while India produces half of the country's generics, with 54% higher severe adverse event rates than domestic drugs. Tariffs will rebuild secure domestic production without raising patient costs since middlemen absorb the increases.

Coalition For A Prosperous America

Anti-Trump narrative

Pharmaceutical tariffs will devastate patients with $600 annual cost increases per household and trigger dangerous drug shortages. Complex supply chains take 5-10 years to rebuild domestically at billions in costs, making immediate reshoring impossible. Generic manufacturers may abandon low-margin drugs entirely — creating critical medication shortages for cancer and antibiotic treatments.